Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Scatena Roberto

From Bioblast
Revision as of 09:54, 28 April 2016 by Fleischmann Sandra (talk | contribs) (moved Scatena Roberto to Scatena R over redirect)


MiPsociety
News and Events        
BEC 2020.1 Mitochondrial physiology
       
MitoEAGLE
        Working Groups         Short-Term Scientific Missions         Management Committee         Members        
MitoGlobal
   


EU-logo.jpg

COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping


Scatena Roberto


MitoPedia topics: EAGLE 

COST: Participant


COST WG4: WG4


Name Scatena Roberto, Prof. PhD
Institution Istituto di Biochimica e Biochimica Clinica

Policlinico A. Gemelli - Universitร  Cattolica

Address Largo A. Gemelli 8, 00168
City Rome
State/Province
Country Italy
Email [email protected]
Weblink
O2k-Network Lab IT Rome Scatena R


MITOEAGLE Feedback

Specifically, we are studying mitochondrial metabolism in cancer cells. At this aim we are also participating to mt-HPP project, an Italian consortium whose target is a definition of mitochondrial proteome in health and disease. Briefly, my specific activity is to compare mitochondrial functional status with the mitochondrial proteome picture in different human cell line. I do think that a "contact" between these two important initiatives should be useful for both. - Scatena Roberto (2016).

New Open Access Journal

Dr. R. Scatena is the editor of 'Cancer Stem Cells'.


Labels: Field of research: Basic 



Publications

 PublishedReference
BEC 2020.1 doi10.26124bec2020-0001.v12020Gnaiger E et al โ€• MitoEAGLE Task Group (2020) Mitochondrial physiology. Bioenerg Commun 2020.1. https://doi.org/10.26124/bec:2020-0001.v1
Bottoni 2019 Adv Exp Med Biol2019Bottoni P, Scatena R (2019) Mitochondrial metabolism in cancer. A tangled topic. Which role for proteomics? Adv Exp Med Biol 1158:1-16.
Scatena 2019 Curr Med Chem2019Scatena R, Bottoni P (2019) The tangled mitochondrial metabolism in cancer: An innovative pharmacological approach. Curr Med Chem 27:2106-17.
Tesori 2015 Sci Rep2015Tesori V, Piscaglia AC, Samengo D, Barba M, Bernardini C, Scatena R, Pontoglio A, Castellini L, Spelbrink JN, Maulucci G, Puglisi MA, Pani G, Gasbarrini A (2015) The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing. Sci Rep 5:9149.
Scatena 2012 Adv Exp Med Biol2012Scatena R, Bottoni P, Giardina B (eds) (2012) Advances in mitochondrial medicine. Adv Exp Med Biol 942:p461.

Abstracts

 PublishedReference
Scatena 2018 MiP20182018
Scatena Roberto
No abstract.
Scatena 2017 Abstract MITOEAGLE Barcelona2017
COST Action MITOEAGLE
Mitochondria and cancer stem cells in hepatocarcinoma. An illustrative example of a tangled methodological approach.
Scatena 2017 MITOEAGLE Obergurgl2017
Roberto Scatena
Cancer stem cell differentiation induced by PPAR ligands. Which role for an inhibition of mitochondrial respiratory chain?